Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
World Journal of Surgery|February 14, 2006
Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidismTuan H Pham, Sylvester Sterioff, Brian P Mullan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcomaPeter M Anderson, Gregory A Wiseman, Linda Erlandson, et al.Leukemia & Lymphoma|January 8, 2024
The asymptomatic follicular lymphoma (AFL) trial: single-agent rituximab immunotherapy versus 90Y-ibritumomab tiuxetan radioimmunotherapy (RIT) for patients with new, untreated follicular lymphomaChonlada Laoruangroj, Pamela J Atherton, Gregory A Wiseman, et al.Mayo Clinic Proceedings|March 21, 2021
Inability of Radioiodine Remnant Ablation to Improve Postoperative Outcome in Adult Patients with Low-Risk Papillary Thyroid CarcinomaIan D Hay, Suneetha Kaggal, Nicole M Iniguez-Ariza, et al.Frontiers in Oncology|November 28, 2012
Progress in gene therapy for prostate cancerKamran A Ahmed, Brian J Davis, Torrence M Wilson, et al.Clinical Lymphoma, Myeloma & Leukemia|April 11, 2022
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone LymphomaMuhamad Alhaj Moustafa, Jennifer Peterson, Bradford S Hoppe, et al.Clinical Nuclear Medicine|April 7, 2007
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphomaDimitrios Karantanis, Brian P O'Neill, Rathan M Subramaniam, et al.Pancreas|July 29, 2010
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomasJonathan R Strosberg, Domenico Coppola, David S Klimstra, et al.Journal of the American Academy of Dermatology|May 4, 2012
The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinomaMichael B Colgan, Tina I Tarantola, Amy L Weaver, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Safety of yttrium-90 ibritumomab tiuxetan radioimmunotherapy for relapsed low-grade, follicular, or transformed non-hodgkin's lymphomaThomas E Witzig, Christine A White, Leo I Gordon, et al.Pageof 6